Aspire Biopharma Holdings Inc
NASDAQ:ASBP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Aspire Biopharma Holdings Inc
NASDAQ:ASBP
|
PR |
|
Hong Kong Exchanges and Clearing Ltd
F:HK2
|
HK |
|
E
|
Eni SpA
F:ENI1
|
IT |
|
M
|
Maple Leaf Foods Inc
F:M1L
|
CA |
|
Cannabist Company Holdings Inc
OTC:CBSTF
|
US |
|
N
|
National Bank of Greece SA
SWB:NAGF
|
GR |
|
U
|
Unum Group
F:UUM
|
US |
|
D
|
Daetwyler Holding AG
SWB:31D1
|
CH |
|
MiniMax Group Inc
HKEX:100
|
CN |
|
Sparc AI Inc
OTC:SPAIF
|
AU |
|
Customers Bancorp Inc
NYSE:CUBI
|
US |
|
B
|
Bitfarms Ltd
NASDAQ:BITF
|
CA |
|
M
|
MDxHealth SA
F:O6C0
|
BE |
|
Danakali Ltd
ASX:DNK
|
AU |
|
Domino's Pizza Group PLC
LSE:DOM
|
UK |
|
D
|
Dover Corp
F:DOV
|
US |
|
Cenergy Holdings SA
LSE:0RL2
|
BE |
|
Kairos Minerals Ltd
OTC:KAIFF
|
AU |
|
F
|
First Mining Gold Corp
LSE:0P07
|
CA |
|
M
|
Merck & Co Inc
PAR:MRK
|
US |
|
X
|
XOMA Corp
F:X0M1
|
US |
|
C
|
Close Brothers Group PLC
OTC:CBGPF
|
UK |
|
Corporacion America Airports SA
NYSE:CAAP
|
LU |
|
M
|
Mitsubishi UFJ Financial Group Inc
F:MFZ
|
JP |
Bankruptcy Probability
Aspire Biopharma Holdings Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Aspire Biopharma Holdings Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PR |
|
Aspire Biopharma Holdings Inc
NASDAQ:ASBP
|
7.8m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
620.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
306.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
237.7B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
191.8B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
259.2B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Aspire Biopharma Holdings Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Aspire Biopharma Holdings Inc has total debt of 5.2m USD. This includes both short-term (5.2m USD) and long-term (0 USD) debt.
You can find a full breakdown on its Balance Sheet.
